Trent R. Hummel - Concepedia

Author

Trent R. Hummel

Cincinnati Children's Hospital Medical Center

Also Known As

Hummel, Trent, Packer, Roger, T Hummel, T. R. Hummel, T.R. Hummel, Trent Hummel, Trent R Hummel, Trent R. Hummel, Trent Ryan Hummel

106

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center Johns Hopkins University National Cancer Institute St. Jude Children's Research Hospital Hospital for Sick Children

About

Trent R. Hummel is an author at Cincinnati Children's Hospital Medical Center specializing in neuro-oncology, glioma, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	495
2	Health Sciences	3	3	66
3	Engineering	1	1	75
4	Social Sciences	1	1	20
5	Diagnostic Sciences	1	1	33

Trent R. Hummel

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis MJ Fisher, Michael J. Loguidice, David H. Gutmann, Neuro-Oncology	2012	300
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics Lindsey M. Hoffman, Mariko DeWire, Scott Ryall, Acta Neuropathologica Communications	2016	195
The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1 Carlos E. Prada, Robert B. Hufnagel, Trent R. Hummel, The Journal of Pediatrics Neuro-oncologyPediatric Brain TumorsOphthalmologyOptic Pathway GliomasNeuroimaging	2015	104
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study Ralph Salloum, Trent R. Hummel, Shiva Senthil Kumar, Journal of Neuro-Oncology Neuro-oncologyTumoral PathologyPediatric Brain TumorsMolecular BiologyPathology	2016	102
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation–Positive Solid Tumors Mark W. Kieran, Birgit Geoerger, Ira J. Dunkel, Clinical Cancer Research	2019	91
Current whole-body MRI applications in the neurofibromatoses Shivani Ahlawat, Laura M. Fayad, Muhammad Shayan Khan, Neurology	2016	85
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study Trent R. Hummel, Lars M. Wagner, Charlotte H. Ahern, Pediatric Blood & Cancer	2013	84
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas Ralph Salloum, Melissa K. McConechy, Leonie G. Mikael, Acta Neuropathologica Communications Pediatric Brain TumorsEngineeringPathologyDisease Gene IdentificationHigh-grade Gliomas	2017	75
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas Trent R. Hummel, Ralph Salloum, Rachid Drissi, Journal of Neuro-Oncology Neuro-oncologyMedicineBevacizumab-based TherapyNeurologyHigh-grade Gliomas	2015	51
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) Mariko DeWire‐Schottmiller, Christine Fuller, Trent R. Hummel, Journal of Neuro-Oncology Neuro-oncologyPediatric Brain TumorsRadiation TherapyPhase I/ii StudyMedicine	2020	48

Page 1